Source author record

Cynthia Sin Nga Lam

Cynthia Sin Nga Lam appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
4topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2021arXiv

Mapping the Landscape of Artificial Intelligence Applications against COVID-19

COVID-19, the disease caused by the SARS-CoV-2 virus, has been declared a pandemic by the World Health Organization, which has reported over 18 million confirmed cases as of August 5, 2020. In this review, we present an overview of recent studies using Machine Learning and, more broadly, Artificial Intelligence, to tackle many aspects of the COVID-19 crisis. We have identified applications that address challenges posed by COVID-19 at different scales, including: molecular, by identifying new or existing drugs for treatment; clinical, by supporting diagnosis and evaluating prognosis based on medical imaging and non-invasive measures; and societal, by tracking both the epidemic and the accompanying infodemic using multiple data sources. We also review datasets, tools, and resources needed to facilitate Artificial Intelligence research, and discuss strategic considerations related to the operational implementation of multidisciplinary partnerships and open science. We highlight the need for international cooperation to maximize the potential of AI in this and future pandemics.

preprint2020arXiv

Considerations, Good Practices, Risks and Pitfalls in Developing AI Solutions Against COVID-19

The COVID-19 pandemic has been a major challenge to humanity, with 12.7 million confirmed cases as of July 13th, 2020 [1]. In previous work, we described how Artificial Intelligence can be used to tackle the pandemic with applications at the molecular, clinical, and societal scales [2]. In the present follow-up article, we review these three research directions, and assess the level of maturity and feasibility of the approaches used, as well as their potential for operationalization. We also summarize some commonly encountered risks and practical pitfalls, as well as guidelines and best practices for formulating and deploying AI applications at different scales.